Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 213.00 | |
50 mg | In stock | $ 347.00 | |
100 mg | In stock | $ 563.00 | |
200 mg | In stock | $ 786.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 70.00 |
Description | SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM. |
Targets&IC50 | MOR:NA |
In vitro | SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM. SR17018 shows no obvious effect on inducing βarrestin2 recruitment to the MOR at below 10 μM. SR17018 promotes signaling through G proteins or βarrestin2 |
Molecular Weight | 410.72 |
Formula | C19H18Cl3N3O |
CAS No. | 2134602-45-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.11 mg/mL (10 mM), Sonification/heating is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SR17018 2134602-45-0 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor SR 17018 SR-17018 inhibit Inhibitor inhibitor